210 related articles for article (PubMed ID: 33216130)
1. Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction.
Meyer-Myklestad MH; Medhus AW; Lorvik KB; Seljeflot I; Hansen SH; Holm K; Stiksrud B; Trøseid M; Hov JR; Kvale D; Dyrhol-Riise AM; Kummen M; Reikvam DH
J Infect Dis; 2022 Feb; 225(4):661-674. PubMed ID: 33216130
[TBL] [Abstract][Full Text] [Related]
2. Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum.
Meyer-Myklestad MH; Medhus AW; Stiksrud B; Lorvik KB; Seljeflot I; Hansen SH; Holm K; Hov JR; Kvale D; Dyrhol-Riise AM; Kummen M; Trøseid M; Reikvam DH
J Acquir Immune Defic Syndr; 2022 Jan; 89(1):77-86. PubMed ID: 34878437
[TBL] [Abstract][Full Text] [Related]
3. Landscape of gut mucosal immune cells showed gap of follicular or memory B cells into plasma cells in immunological non-responders.
Wang Z; Zhen C; Guo X; Qu M; Zhang C; Song J; Fan X; Huang H; Xu R; Zhang J; Yuan J; Hong W; Li J; Wang FS; Jiao YM; Linghu E
Clin Transl Med; 2024 May; 14(5):e1699. PubMed ID: 38783408
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4
Lorvik KB; Meyer-Myklestad MH; Kushekar K; Handeland C; Medhus AW; Lund-Iversen M; Stiksrud B; Kvale D; Dyrhol-Riise AM; Taskén K; Reikvam DH
Front Immunol; 2021; 12():744155. PubMed ID: 34691047
[TBL] [Abstract][Full Text] [Related]
5. The Imbalance Between Intestinal Th17 and Treg Cells Is Associated with an Incomplete Immune Reconstitution During Long-Term Antiretroviral Therapy in Patients with HIV.
Guo YT; Guo XY; Fan LN; Wang ZR; Qu MM; Zhang C; Fan X; Song JW; Yang BP; Zhang JY; Xu R; Jiao YM; Ma P; Chen YK; Wang FS
Viral Immunol; 2023 Jun; 36(5):331-342. PubMed ID: 37184871
[TBL] [Abstract][Full Text] [Related]
6. Association between CD4
Lu D; Zhang JB; Wang YX; Geng ST; Zhang Z; Xu Y; Li SY; Wang KH; Kuang YQ
BMC Infect Dis; 2021 Aug; 21(1):742. PubMed ID: 34344350
[TBL] [Abstract][Full Text] [Related]
7. Whole-protein enteral nutrition formula supplementation reduces
Lu D; Wang YX; Geng ST; Zhang Z; Xu Y; Peng QY; Li SY; Zhang JB; Wang KH; Kuang YQ
Appl Physiol Nutr Metab; 2024 Mar; 49(3):319-329. PubMed ID: 37922515
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: A High Rate of β7+ Gut-Homing Lymphocytes in HIV-Infected Immunological Nonresponders is Associated With Poor CD4 T-Cell Recovery During Suppressive HAART.
Girard A; Vergnon-Miszczycha D; Depincé-Berger AE; Roblin X; Lutch F; Lambert C; Rochereau N; Bourlet T; Genin C; Paul S
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):259-65. PubMed ID: 27306505
[TBL] [Abstract][Full Text] [Related]
9. Increased early activation of CD56dimCD16dim/- natural killer cells in immunological non-responders correlates with CD4+ T-cell recovery.
Zhang QY; Zhang X; Su B; Liu LF; Yang XD; Tang B; Xia H; Ma P; Zhang T; Wu H
Chin Med J (Engl); 2020 Nov; 133(24):2928-2939. PubMed ID: 33252378
[TBL] [Abstract][Full Text] [Related]
10. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A
World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423
[TBL] [Abstract][Full Text] [Related]
11. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.
Mavigner M; Cazabat M; Dubois M; L'Faqihi FE; Requena M; Pasquier C; Klopp P; Amar J; Alric L; Barange K; Vinel JP; Marchou B; Massip P; Izopet J; Delobel P
J Clin Invest; 2012 Jan; 122(1):62-9. PubMed ID: 22156200
[TBL] [Abstract][Full Text] [Related]
12. Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.
Tincati C; Merlini E; Braidotti P; Ancona G; Savi F; Tosi D; Borghi E; Callegari ML; Mangiavillano B; Barassi A; Bulfamante G; d'Arminio Monforte A; Romagnoli S; Chomont N; Marchetti G
AIDS; 2016 Apr; 30(7):991-1003. PubMed ID: 27028142
[TBL] [Abstract][Full Text] [Related]
13. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
14. The predictive role of CD4
Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
[TBL] [Abstract][Full Text] [Related]
15. Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers.
Kim CJ; Rousseau R; Huibner S; Kovacs C; Benko E; Shahabi K; Kandel G; Ostrowski M; Kaul R
AIDS; 2017 Jul; 31(11):1529-1534. PubMed ID: 28463882
[TBL] [Abstract][Full Text] [Related]
16. An atlas of immune cell transcriptomes in human immunodeficiency virus-infected immunological non-responders identified marker genes that control viral replication.
Chen Y; Li X; Liu S; Ao W; Lin J; Li Z; Wu S; Ye H; Han X; Li D
Chin Med J (Engl); 2023 Nov; 136(22):2694-2705. PubMed ID: 37914674
[TBL] [Abstract][Full Text] [Related]
17. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis.
Kim CJ; Nazli A; Rojas OL; Chege D; Alidina Z; Huibner S; Mujib S; Benko E; Kovacs C; Shin LY; Grin A; Kandel G; Loutfy M; Ostrowski M; Gommerman JL; Kaushic C; Kaul R
Mucosal Immunol; 2012 Nov; 5(6):670-80. PubMed ID: 22854709
[TBL] [Abstract][Full Text] [Related]
18. Th17 cells, HIV and the gut mucosal barrier.
Dandekar S; George MD; Bäumler AJ
Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
[TBL] [Abstract][Full Text] [Related]
19. Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals.
Fernandes SM; Pires AR; Ferreira C; Foxall RB; Rino J; Santos C; Correia L; Poças J; Veiga-Fernandes H; Sousa AE
J Infect Dis; 2014 Aug; 210(4):630-40. PubMed ID: 24604817
[TBL] [Abstract][Full Text] [Related]
20. Pathological proliferation: a potential mechanism for poor CD4
Zhang Y; Ji J; Xie K; Cai M; Wang R; Zhang X; Chen X; Zhang Y; Wu H; Wang W; Li Z; Zhang T
Front Cell Infect Microbiol; 2024; 14():1344778. PubMed ID: 38601742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
